Kang SH - Search Results

1

Effect of exercise-based interventions in nonalcoholic fatty liver disease: A systematic review with meta-analysis.

Nam H, Yoo JJ, Cho Y, Kang SH, Ahn SB, Lee HW, Jun DW, Song DS, Choi M. Nam H, et al. Among authors: kang sh. Dig Liver Dis. 2023 Sep;55(9):1178-1186. doi: 10.1016/j.dld.2022.12.013. Epub 2023 Jan 16. Dig Liver Dis. 2023. PMID: 36653265 Review.

2

Efficacy of telbivudine compared with entecavir in hepatitis B virus-related cirrhosis: 2 year follow-up data.

Kim HR, Yim HJ, Kang S, Suh SJ, Kim SY, Hyun JJ, Koo JS, Kim JH, Seo YS, Yeon JE, Lee SW, Byun KS, Um SH. Kim HR, et al. Among authors: kang s. Liver Int. 2015 Mar;35(3):860-9. doi: 10.1111/liv.12605. Epub 2014 Jul 5. Liver Int. 2015. PMID: 24905912

3

Treatment of Severe Alcoholic Hepatitis With Corticosteroid, Pentoxifylline, or Dual Therapy: A Systematic Review and Meta-Analysis.

Lee YS, Kim HJ, Kim JH, Yoo YJ, Kim TS, Kang SH, Suh SJ, Joo MK, Jung YK, Lee BJ, Seo YS, Yim HJ, Yeon JE, Kim JS, Park JJ, Um SH, Bak YT, Byun KS. Lee YS, et al. Among authors: kang sh. J Clin Gastroenterol. 2017 Apr;51(4):364-377. doi: 10.1097/MCG.0000000000000674. J Clin Gastroenterol. 2017. PMID: 27636406 Review.

4

Dynamics of liver stiffness-based risk prediction model during antiviral therapy in patients with chronic hepatitis B.

Chon HY, Seo YS, Lee JI, Kim BS, Jang BK, Kim SG, Suk KT, Kim IH, Lee JW, Chon YE, Kim MY, Jeong SW, Lee HA, Yim SY, Um SH, Lee HW, Lee KS, Song JE, Lee CH, Chung WJ, Hwang JS, Yoo JJ, Kim YS, Kim DJ, Lee CH, Yu JH, Ha YJ, Kim MN, Lee JH, Hwang SG, Kang SH, Baik SK, Jang JY, Suh SJ, Jung YK, Kim BK, Park JY, Kim DY, Ahn SH, Han KH, Yim HJ, Kim SU; Korean Transient Elastography Study Group. Chon HY, et al. Among authors: kang sh. Eur J Gastroenterol Hepatol. 2021 Jun 1;33(6):885-893. doi: 10.1097/MEG.0000000000001794. Eur J Gastroenterol Hepatol. 2021. PMID: 32541238

5

Empirical Treatment With Carbapenem vs Third-generation Cephalosporin for Treatment of Spontaneous Bacterial Peritonitis.

Kim SW, Yoon JS, Park J, Jung YJ, Lee JS, Song J, Lee HA, Seo YS, Lee M, Park JM, Choi DH, Kim MY, Kang SH, Yang JM, Song DS, Chung SW, Kim MA, Jang HJ, Oh H, Lee CH, Lee YB, Cho EJ, Yu SJ, Kim YJ, Yoon JH, Lee JH. Kim SW, et al. Among authors: kang sh. Clin Gastroenterol Hepatol. 2021 May;19(5):976-986.e5. doi: 10.1016/j.cgh.2020.06.046. Epub 2020 Jul 2. Clin Gastroenterol Hepatol. 2021. PMID: 32623007

6

Prognosis predictability of serum and urine renal markers in patients with decompensated cirrhosis: A multicentre prospective study.

Kim TH, Seo YS, Kang SH, Kim MY, Kim SG, Lee HY, Lee JH, Lee YS, Kim JH, Jeong SW, Jang JY, Suk KT, Jung YK, An H, Yim HJ, Kim YS, Um SH; Korean Study Group of Portal Hypertension. Kim TH, et al. Among authors: kang sh. Liver Int. 2020 Dec;40(12):3083-3092. doi: 10.1111/liv.14631. Liver Int. 2020. PMID: 32750739

7

Application of Hepatic Venous Pressure Gradient to Predict Prognosis in Cirrhotic Patients with a Low Model for End-Stage Liver Disease Score.

Chang Y, Suk KT, Jeong SW, Yoo JJ, Kim SG, Kim YS, Lee SH, Kim HS, Kang SH, Baik SK, Kim DJ, Kim MY, Jang JY. Chang Y, et al. Among authors: kang sh. Diagnostics (Basel). 2020 Oct 10;10(10):805. doi: 10.3390/diagnostics10100805. Diagnostics (Basel). 2020. PMID: 33050413 Free PMC article.

8

The cut-off value of transient elastography to the value of hepatic venous pressure gradient in alcoholic cirrhosis.

Ryu SR, Yoo JJ, Kang SH, Jeong SW, Kim MY, Cho YK, Chang Y, Kim SG, Jang JY, Kim YS, Baik SK, Kim YJ, Park SY, Baymbajav B. Ryu SR, et al. Among authors: kang sh. Clin Mol Hepatol. 2021 Jan;27(1):197-206. doi: 10.3350/cmh.2020.0171. Epub 2020 Dec 3. Clin Mol Hepatol. 2021. PMID: 33317252 Free PMC article.

9

From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?

Kang SH, Cho Y, Jeong SW, Kim SU, Lee JW; Korean NAFLD Study Group. Kang SH, et al. Clin Mol Hepatol. 2021 Apr;27(2):257-269. doi: 10.3350/cmh.2021.0067. Epub 2021 Mar 22. Clin Mol Hepatol. 2021. PMID: 33751877 Free PMC article. Review.

10

KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease.

Kang SH, Lee HW, Yoo JJ, Cho Y, Kim SU, Lee TH, Jang BK, Kim SG, Ahn SB, Kim H, Jun DW, Choi JI, Song DS, Kim W, Jeong SW, Kim MY, Koh H, Jeong S, Lee JW, Cho YK; Korean Association for the Study of the Liver (KASL). Kang SH, et al. Clin Mol Hepatol. 2021 Jul;27(3):363-401. doi: 10.3350/cmh.2021.0178. Epub 2021 Jun 22. Clin Mol Hepatol. 2021. PMID: 34154309 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,699 results

Search Page